Contracts › 75N91024F00002
75N91024F00002: Manufacture of Plasmid Dna Drug Substance and Drug Product
Awarded to Mriglobal by National Institutes of Health (NIH).
$2.8Mobligated
$2.8Mpotential value
30 April 2028current end date
See modifications, all subcontractors and funding in FedSift →
| Contract | 75N91024F00002 |
|---|---|
| Vehicle | 75N91023D00010 |
| Awardee | Mriglobal |
| Awarding agency | National Institutes of Health (NIH) |
| Awarding office | NIH NCI |
| NAICS | 541690 Other Scientific and Technical Consulting Services |
| PSC | Q301 Reference Laboratory Testing |
| Place of performance | MD |
| Period of performance | 25 September 2024 to 30 April 2028 |
| Potential end | 30 April 2028 |
| Estimated recompete solicitation | ~Q4 2027 (estimate, ~6 months before expiry) |
Source: USASpending.gov (FPDS), public federal procurement data, as the agency reported it. Our record updated 04 October 2026. The solicitation date is an estimate from the end date, not a posted date.
Other expiring 541690 contracts · All expiring contracts · USASpending record